Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 885825 | ISIN: US4525253062 | Ticker-Symbol: IUL
Frankfurt
27.06.25 | 08:00
5,650 Euro
+8,65 % +0,450
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
IMMUCELL CORPORATION Chart 1 Jahr
5-Tage-Chart
IMMUCELL CORPORATION 5-Tage-Chart

Aktuelle News zur IMMUCELL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiIMMUCELL CORP /DE/ - 8-K, Current Report1
MiImmuCell initiates CEO succession search ahead of planned 2026 retirement1
17.06.IMMUCELL CORP /DE/ - 8-K, Current Report1
05.06.ImmuCell Corporation: ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders1
IMMUCELL Aktie jetzt für 0€ handeln
14.05.ImmuCell Q2 2025 slides: sales momentum continues as Re-Tain awaits FDA approval1
14.05.ImmuCell GAAP EPS of $0.161
12.05.ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 20251
08.04.ImmuCell reports record sales in first quarter of 20251
08.04.ImmuCell verzeichnet Rekordumsatz im ersten Quartal 20252
08.04.ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025417PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
07.04.IMMUCELL CORP /DE/ - 8-K, Current Report1
07.04.ImmuCell Hires Timothy Fiori As CFO-
07.04.ImmuCell appoints new CFO to bolster growth strategy1
07.04.ImmuCell Corporation: ImmuCell Hires Chief Financial Officer133PORTLAND, Maine, April 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
02.04.ImmuCell Corporation: ImmuCell Announces Initiation of Investigational Product Use of Re-Tain111PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
28.03.IMMUCELL CORP /DE/ - 10-K, Annual Report3
25.02.ImmuCell GAAP EPS of $0.06, revenue of $7.75M1
25.02.ImmuCell Corporation: ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024141PORTLAND, Maine, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
25.02.IMMUCELL CORP /DE/ - 8-K, Current Report-
20.02.ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 20241
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1